934 related articles for article (PubMed ID: 17190867)
1. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
[TBL] [Abstract][Full Text] [Related]
2. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
[TBL] [Abstract][Full Text] [Related]
3. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
[TBL] [Abstract][Full Text] [Related]
5. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
6. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
[TBL] [Abstract][Full Text] [Related]
7. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
9. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
[TBL] [Abstract][Full Text] [Related]
10. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy.
Sumner AD; Boehmer JP; Saxon LA; Carson P; Feldman AM; Galle E; Bristow MR
Congest Heart Fail; 2009; 15(4):159-64. PubMed ID: 19627288
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
[TBL] [Abstract][Full Text] [Related]
12. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
13. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.
Auricchio A; Metra M; Gasparini M; Lamp B; Klersy C; Curnis A; Fantoni C; Gronda E; Vogt J;
Am J Cardiol; 2007 Jan; 99(2):232-8. PubMed ID: 17223424
[TBL] [Abstract][Full Text] [Related]
16. Why should we care about CARE-HF?
Ellenbogen KA; Wood MA; Klein HU
J Am Coll Cardiol; 2005 Dec; 46(12):2199-203. PubMed ID: 16360046
[TBL] [Abstract][Full Text] [Related]
17. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.
Carson P; Anand I; O'Connor C; Jaski B; Steinberg J; Lwin A; Lindenfeld J; Ghali J; Barnet JH; Feldman AM; Bristow MR
J Am Coll Cardiol; 2005 Dec; 46(12):2329-34. PubMed ID: 16360067
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.
Feldman AM; de Lissovoy G; Bristow MR; Saxon LA; De Marco T; Kass DA; Boehmer J; Singh S; Whellan DJ; Carson P; Boscoe A; Baker TM; Gunderman MR
J Am Coll Cardiol; 2005 Dec; 46(12):2311-21. PubMed ID: 16360064
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.
Foley PW; Chalil S; Khadjooi K; Smith RE; Frenneaux MP; Leyva F
Europace; 2008 Nov; 10(11):1302-7. PubMed ID: 18827063
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
Bristow MR; Saxon LA; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; DeMets D; White BG; DeVries DW; Feldman AM;
N Engl J Med; 2004 May; 350(21):2140-50. PubMed ID: 15152059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
